Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.180
+0.060 (5.36%)
Apr 14, 2026, 5:24 PM CET
-64.78% (1Y)
| Market Cap | 35.87M -53.2% |
| Revenue (ttm) | 36.76M +14.2% |
| Net Income | -25.78M |
| EPS | -0.94 |
| Shares Out | 30.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 80,284 |
| Average Volume | 74,423 |
| Open | 1.155 |
| Previous Close | 1.120 |
| Day's Range | 1.150 - 1.275 |
| 52-Week Range | 0.760 - 3.400 |
| Beta | 1.09 |
| RSI | 54.62 |
| Earnings Date | Apr 15, 2026 |